Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis-Reference-Cited by-同舟云学术

Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis

Published:2019-08-07 Issue:5 Volume:13 Page:641-648
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Kamal Natasha, ,Koh Christopher,Samala Niharika,Fontana Robert J.,Stolz Andrew,Durazo Francisco,Hayashi Paul H.,Phillips Elizabeth,Wang Tongrong,Hoofnagle Jay H.

Funder

NIDDK

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

http://link.springer.com/content/pdf/10.1007/s12072-019-09971-2.pdf

Reference29 articles.

1. Egler RA, Ahuja SP, Matloub Y. l-asparaginase in the treatment of patients with acute lymphoblastic leukemia. J Pharmacol Pharmacother 2016;7:62–71

2. Raetz EA, Salzer WL. Tolerability and efficacy of l-asparaginase therapy in pediatric patients with acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2010;32:554–563

3. Horowitz B, Madras BK, Meister A, et al. Asparagine synthetase activity of mouse leukemias. Science 1968;160:533–535

4. Broome JD. Studies on the mechanism of tumor inhibition by l-asparaginase. Effects of the enzyme on asparagine levels in the blood, normal tissues, and 6C3HED lymphomas of mice: differences in asparagine formation and utilization in asparaginase-sensitive and -resistant lymphoma cells. J Exp Med 1968;127:1055–1072

5. Earl M. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin Adv Hematol Oncol 2009;7:600–606

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic veno-occlusive disease with asparaginase products: a review of cases reported to the FDA adverse event reporting system and published in the literature;Pediatric Hematology and Oncology;2024-08-28

2. l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development;Advanced Therapeutics;2024-08-19

3. Exploring the potential of asparagine restriction in solid cancer treatment: recent discoveries, therapeutic implications, and challenges;Medical Oncology;2024-06-15

4. Review article: Hepatic steatosis and its associations with acute and chronic liver diseases;Alimentary Pharmacology & Therapeutics;2024-06-07

5. Retrospective review of the toxicities and change in dosing patterns for pegaspargase in patients with acute lymphoblastic leukemia/lymphoma and T-cell lymphoma;Journal of Oncology Pharmacy Practice;2024-04-13